Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients (Frontiers in Oncology, (2023), 13, (1280587), 10.3389/fonc.2023.1280587)
- Ema Mosleh
- , Stacy Snyder
- , Ningying Wu
- , Daniel N. Willis
- , Rema Malone
- , Robert J. Hayashi
Research output: Contribution to journal › Comment/debate